In this special episode, Dr Cheryl Lai, Acting Deputy Editor at The Lancet Oncology, is joined by Dr Raffaella Casolino (University of Glasgow, UK; International Cancer Genome Consortium - Accelerating Research in Genomic Oncology) and Professor Mark Lawler (Queen's University Belfast, UK) to discuss the outcomes and implications of the latest Lancet Oncology Commission on cccelerating equitable cancer genomics and precision oncology in health care and research.

Explore the Commission and related content:

https://www.thelancet.com/commissions-do/accelerating-equitable-cancer-genomics

Look at the infographic:

https://www.thelancet.com/infographics-do/universal-access-precision-oncology

Read the full Commission:

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00302-5

Podden och tillhörande omslagsbild på den här sidan tillhör The Lancet Group. Innehållet i podden är skapat av The Lancet Group och inte av, eller tillsammans med, Poddtoppen.